Descriptive, environmental and genetic epidemiology of nasopharyngeal carcinoma

Advances in Experimental Medicine and Biology

Volumn 778, Issue , 2013, Pages 23-41

  Feng, Bing Jian ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Human leukocyte antigen; Human leukocyte antigen allele; Human leukocyte antigen region; Nasopharyngeal carcinoma; Salted fish

Indexed keywords

ALCOHOL; CANNABIS; CARCINOGEN; HLA ANTIGEN CLASS 1;

ARTIC REGION; CANCER RISK; CARCINOGENESIS; CHROMOSOME ABERRATION; CHRONIC RESPIRATORY TRACT DISEASE; COOKING; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FISH; FOOD INTAKE; FOOD PRESERVATION; FRUIT; FUME; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GEOGRAPHIC NAMES; GEOGRAPHY; HUMAN; HUMAN LEUKOCYTE ANTIGEN CLASS I GENE; IMMIGRATION; LEAFY VEGETABLE; NASOPHARYNX CARCINOMA; NONHUMAN; NORTH AFRICA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SOUTHEAST ASIA; TOBACCO; TREND STUDY; VIRUS ACTIVATION;

EID: 85011267696     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5947-7_3     Document Type: Chapter

References (136)

1. Jeannel D, Bouvier G, Hubbert A. Nasopharyngeal Carcinoma: An Epidemiological Approach to Carcinogenesis. Cancer Surveys 1999; 33:125-155.
2. Curado MP, Edwards B, Shin HR et al. Cancer Incidence in Five Continents Vol. IX. Vol IX. Lyon, France: International Agency for Research on Cancer 2007.
3. Kelly J, Lanier A, Santos M et al. Cancer among the circumpolar Inuit, 1989-2003. II. Patterns and trends. Int J Circumpolar Health 2008; 67(5):408-420.
4. Nandakumar A, Gupta PC, Gangadharan P et al. Geographic pathology revisited: development of an atlas of cancer in India. Int J Cancer 2005; 116(5):740-754.
5. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12(6):421-429.
6. Devi BC, Pisani P, Tang TS, Parkin DM. High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island. Cancer Epidemiol Biomarkers Prev 2004; 13(3):482-486.
7. Bray F, Haugen M, Moger TA et al. Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev 2008; 17(9):2356-2365.
8. Ellouz R, Cammoun M, Attia RB et al. Nasopharyngeal carcinoma in children and adolescents in Tunisia: clinical aspects and the paraneoplastic syndrome. IARC Sci Publ 1978; (20):115-129.
9. Barnes L, Eveson JW, Reichart P et al. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005.
10. Zong YS, Zhang RF, He SY et al. Histopathologic types and incidence of malignant nasopharyngeal tumors in Zhongshan County. Chin Med J (Engl) 1983; 96(7):511-516.
11. Feng BJ, Khyatti M, Ben-Ayoub W et al. Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa. Br J Cancer 2009; 101(7):1207-1212.
12. Friborg JT, Melbye M. Cancer patterns in Inuit populations. Lancet Oncol 2008; 9(9):892-900.
13. Ou SH, Zell JA, Ziogas A et al. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 2007; 18(1):29-35.
14. Shanmugaratnam K, Sobin LH. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition. Cancer 1993; 71(8):2689-2697.
15. Nicholls JM, Agathanggelou A, Fung K et al. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt’s lymphoma. J Pathol 1997; 183(2):164-168.
16. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15(10):1765-1777.
17. Sun LM, Epplein M, Li CI et al. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002. Am J Epidemiol 2005; 162(12):1174-1178.
18. Jia WH, Huang QH, Liao J et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer 2006; 6:178.
19. Tse LA, Yu IT, Mang OW et al. Incidence rate trends of histological subtypes of nasopharyngeal carcinoma in Hong Kong. Br J Cancer 2006; 95(9):1269-1273.
20. Luo J, Chia KS, Chia SE et al. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997. Eur J Epidemiol 2007; 22(8):513-521.
21. Boysen T, Friborg J, Andersen A et al. The Inuit cancer pattern—the influence of migration. Int J Cancer 2008; 122(11):2568-2572.
22. Tao Q, Young LS, Woodman CB et al. Epstein-Barr virus (EBV) and its associated human cancers—genetics, epigenetics, pathobiology and novel therapeutics. Front Biosci 2006; 11:2672-2713.
23. Sriamporn S, Vatanasapt V, Pisani P, Yongchaiyudha S, Rungpitarangsri V. Environmental risk factors for nasopharyngeal carcinoma: a case-control study in northeastern Thailand. Cancer Epidemiol Biomarkers Prev 1992; 1(5):345-348.
24. IARC. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Monogr Eval Carcinog Risks Hum 1993; 56.
25. Lanier A, Bender T, Talbot M et al. Nasopharyngeal carcinoma in Alaskan Eskimos Indians, and Aleuts: a review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors. Cancer 1980; 46(9):2100-2106.
26. Gallicchio L, Matanoski G, Tao XG et al. Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review. Int J Cancer 2006; 119(5):1125-1135.
27. Jeannel D, Hubert A, de Vathaire F et al. Diet, living conditions and nasopharyngeal carcinoma in Tunisia—a case-control study. Int J Cancer 1990; 46(3):421-425.
28. Feng BJ, Jalbout M, Ayoub WB et al. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int J Cancer 2007; 121(7):1550-1555.
29. Armstrong RW, Imrey PB, Lye MS et al. Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer 1998; 77(2):228-235.
30. Chen DL, Huang TB. A case-control study of risk factors of nasopharyngeal carcinoma. Cancer Lett 1997; 117(1):17-22.
31. Yu MC, Huang TB, Henderson BE. Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China. Int J Cancer 1989; 43(6):1077-1082.
32. Yu MC, Mo CC, Chong WX et al. Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res 1988; 48(7):1954-1959.
33. Yuan JM, Wang XL, Xiang YB et al. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000; 85(3):358-363.
34. Zheng YM, Tuppin P, Hubert A et al. Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China. Br J Cancer 1994; 69(3):508-514.
35. Farrow DC, Vaughan TL, Berwick M et al. Diet and nasopharyngeal cancer in a low-risk population. Int J Cancer 1998; 78(6):675-679.
36. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 17. Lyon: International Agency for Research on Cancer 1987.
37. Poirier S, Hubert A, de The G et al. Occurrence of volatile nitrosamines in food samples collected in three high-risk areas for nasopharyngeal carcinoma. IARC Sci Publ 1987; (84):415-419.
38. Poirier S, Ohshima H, de The G et al. Volatile nitrosamine levels in common foods from Tunisia, south China and Greenland, high-risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer 1987; 39(3):293-296.
39. Zou X, Li J, Lu S et al. Volatile N-nitrosamines in salted fish samples from high-and low-risk areas for NPC in China. Chin Med Sci J 1992; 7(4):201-204.
40. Zou XN, Lu SH, Liu B. Volatile N-nitrosamines and their precursors in Chinese salted fish—a possible etological factor for NPC in china. Int J Cancer 1994; 59(2):155-158.
41. Poirier S, Bouvier G, Malaveille C et al. Volatile nitrosamine levels and genotoxicity of food samples from high-risk areas for nasopharyngeal carcinoma before and after nitrosation. Int J Cancer 1989; 44(6):1088-1094.
42. Ward MH, Pan WH, Cheng YJ et al. Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int J Cancer 2000; 86(5):603-609.
43. Shao YM, Poirier S, Ohshima H et al. Epstein-Barr virus activation in Raji cells by extracts of preserved food from high risk areas for nasopharyngeal carcinoma. Carcinogenesis 1988; 9(8):1455-1457.
44. Bouvier G, Hergenhahn M, Polack A et al. Characterization of macromolecular lignins as Epstein-Barr virus inducer in foodstuff associated with nasopharyngeal carcinoma risk. Carcinogenesis 1995; 16(8):1879-1885.
45. Bauer G. Quantitative analysis of the cooperative effect between inducers of Epstein-Barr virus antigen synthesis. J Gen Virol 1983; 64 (Pt 6):1337-1346.
46. Zhu K, Levine RS, Brann EA et al. Cigarette smoking and nasopharyngeal cancer: an analysis of the relationship according to age at starting smoking and age at diagnosis. J Epidemiol 1997; 7(2):107-111.
47. Vaughan TL, Shapiro JA, Burt RD et al. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996; 5(8):587-593.
48. Chow WH, McLaughlin JK, Hrubec Z et al. Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans. Int J Cancer 1993; 55(4):538-540.
49. Nam JM, McLaughlin JK, Blot WJ. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U.S. whites. J Natl Cancer Inst 1992; 84(8):619-622.
50. Mabuchi K, Bross DS, Kessler, II. Cigarette smoking and nasopharyngeal carcinoma. Cancer 1985; 55(12):2874-2876.
51. Friborg JT, Yuan JM, Wang R et al. A prospective study of tobacco and alcohol use as risk factors for pharyngeal carcinomas in Singapore Chinese. Cancer 2007; 109(6):1183-1191.
52. Guo X, Johnson RC, Deng H et al. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer 2009; 124(12):2942-2947.
53. Zou J, Sun Q, Akiba S et al. A case-control study of nasopharyngeal carcinoma in the high background radiation areas of Yangjiang, China. J Radiat Res (Tokyo) 2000; 41 Suppl:53-62.
54. Armstrong RW, Imrey PB, Lye MS et al. Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat. Int J Epidemiol 2000; 29(6):991-998.
55. Cheng YJ, Hildesheim A, Hsu MM et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 1999; 10(3):201-207.
56. Yu MC, Garabrant DH, Huang TB et al. Occupational and other nondietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer 1990; 45(6):1033-1039.
57. Chen CJ, Liang KY, Chang YS et al. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 1990; 10(2B):547-553.
58. Yuan JM, Wang XL, Xiang YB et al. Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000; 85(3):364-369.
59. Ning JP, Yu MC, Wang QS et al. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People’s Republic of China. J Natl Cancer Inst 1990;82(4):291-296.
60. Hashibe M, Straif K, Tashkin DP et al. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005; 35(3):265-275.
61. Armstrong RW, Imrey PB, Lye MS et al. Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer 1998; 77(2):228-235.
62. Chen L, Gallicchio L, Boyd-Lindsley K et al. Alcohol consumption and the risk of nasopharyngeal carcinoma: a systematic review. Nutr Cancer 2009; 61(1):1-15.
63. Yu MC, Ho JH, Lai SH et al. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res 1986; 46(2):956-961.
64. Maeda E, Akahane M, Kiryu S et al. Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Jpn J Radiol 2009; 27(1):4-19.
65. Henle W, Henle G, Ho HC et al. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 1970; 44(1):225-231.
66. Chien YC, Chen JY, Liu MY et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 2001; 345(26):1877-1882.
67. Niedobitek G, Hansmann ML, Herbst H et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991; 165(1):17-24.
68. Niedobitek G, Young LS, Sam CK et al. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 1992; 140(4):879-887.
69. Pathmanathan R, Prasad U, Chandrika G et al. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146(6):1355-1367.
70. Pathmanathan R, Prasad U, Sadler R et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333(11):693-698.
71. Pak MW, To KF, Lo YM et al. Nasopharyngeal carcinoma in situ (NPCIS)—pathologic and clinical perspectives. Head Neck 2002; 24(11):989-995.
72. Yeung WM, Zong YS, Chiu CT et al. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 1993; 53(5):746-750.
73. Tao Q, Srivastava G, Chan AC et al. Epstein-Barr-virus-infected nasopharyngeal intraepithelial lymphocytes. Lancet 1995; 345(8960):1309-1310.
74. Tao Q, Srivastava G, Chan AC et al. Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J Med Virol 1995; 45(1):71-77.
75. Tsai ST, Jin YT, Mann RB et al. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Cancer 1998; 82(8):1449-1453.
76. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47(6):883-889.
77. Shimakage M, Chatani M, Ikegami N et al. Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma. Jpn J Cancer Res 1989; 80(7):612-616.
78. Knox PG, Li QX, Rickinson AB et al. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. Virology 1996; 215(1):40-50.
79. Niedobitek G. Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 2000; 53(5):248-254.
80. Chan AS, To KF, Lo KW et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 2000; 60(19):5365-5370.
81. Sengupta S, den Boon JA, Chen IH et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res 2006; 66(16):7999-8006.
82. Shah KM, Young LS. Epstein-Barr virus and carcinogenesis: beyond Burkitt’s lymphoma. Clin Microbiol Infect 2009; 15(11):982-988.
83. Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007; 9(12):1-24.
84. Chang CM, Yu KJ, Mbulaiteye SM et al. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res 2009; 143(2):209-221.
85. IARC. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. IARC Monogr Eval Carcinog Risks Hum 2006; 88.
86. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357(9255):539-545.
87. Shebl FM, Bhatia K, Engels EA. Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. Int J Cancer 2009.
88. Huang YL, Chen YJ, Lin MW et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol 2009; 161(4):854-860.
89. IARC. Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004; 85.
90. Jia WH, Feng BJ, Xu ZL et al. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer 2004; 101(2):363-369.
91. Zhou X, Cui J, Macias V et al. The progress on genetic analysis of nasopharyngeal carcinoma. Comp Funct Genomics 2007; 57513.
92. Shih-Hsin Wu L. Construction of evolutionary tree models for nasopharyngeal carcinoma using comparative genomic hybridization data. Cancer Genet Cytogenet 2006; 168(2):105-108.
93. Huang Z, Desper R, Schaffer AA et al. Construction of tree models for pathogenesis of nasopharyngeal carcinoma. Genes Chromosomes Cancer 2004; 40(4):307-315.
94. Chan AS, To KF, Lo KW et al. Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 2002; 102(3):300-303.
95. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004; 5(5):423-428.
96. Li X, Fasano R, Wang E et al. HLA associations with nasopharyngeal carcinoma. Curr Mol Med 2009; 9(6):751-765.
97. Hildesheim A, Apple RJ, Chen CJ et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002; 94(23):1780-1789.
98. Ren EC, Law GC, Chan SH. HLA-A2 allelic microvariants in nasopharyngeal carcinoma. Int J Cancer 1995; 63(2):213-215.
99. Lu CC, Chen JC, Jin YT et al. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer 2003; 103(6):745-751.
100. Pasini E, Caggiari L, Dal Maso L et al. Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes. Int J Cancer 2009; 125(6):1358-1364.
101. Lee SP, Tierney RJ, Thomas WA et al. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J Immunol 1997; 158(7):3325-3334.
102. Lin JC, Cherng JM, Lin HJ et al. Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted ‘epitope-loss variant’. J Gen Virol 2004; 85(Pt 7):2023-2034.
103. Lin HJ, Cherng JM, Hung MS et al. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan. J Biomed Sci 2005; 12(6):925-936.
104. Midgley RS, Bell AI, Yao QY et al. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. J Virol 2003; 77(21):11507-11516.
105. Xiong W, Zeng ZY, Xia JH et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004; 64(6):1972-1974.
106. Feng BJ, Huang W, Shugart YY et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002; 31(4):395-399.
107. Hu LF, Qiu QH, Fu SM et al. A genome-wide scan suggests a susceptibility locus on 5p 13 for nasopharyngeal carcinoma. Eur J Hum Genet 2008; 16(3):343-349.
108. Lu SJ, Day NE, Degos L et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990; 346(6283):470-471.
109. Hildesheim A, Anderson LM, Chen CJ et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997; 89(16):1207-1212.
110. Hildesheim A, Chen CJ, Caporaso NE et al. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 1995; 4(6):607-610.
111. Yang XR, Diehl S, Pfeiffer R et al. Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiol Biomarkers Prev 2005; 14(4):900-905.
112. Kongruttanachok N, Sukdikul S, Setavarin S et al. Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 2001; 1:4.
113. He ZM, Chen ZC, Yuan JH et al. Expression of Cytochrome p450 2E1 in nasopharynx and polymorphism analysis. Chinese Journal of Pathophysiology 2000; 16(20):1060.
114. Jia WH, Pan QH, Qin HD et al. A Case-Control and a Family-Based Association Study Revealing an Association between CYP2E1 Polymorphisms and Nasopharyngeal Carcinoma Risk in Cantonese. Carcinogenesis 2009.
115. Tiwawech D, Srivatanakul P, Karalak A et al. Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. Cancer Lett 2006; 241(1):135-141.
116. Zhuo X, Cai L, Xiang Z et al. GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res 2009; 28:46.
117. Bendjemana K, Abdennebi M, Gara S et al [Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience]. Bull Cancer 2006; 93(3):297-302.
118. Cho EY, Hildesheim A, Chen CJ et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003; 12(10):1100-1104.
119. Cao Y, Miao XP, Huang MY et al. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 2006; 6:167.
120. Yang ZH, Dai Q, Kong XL et al. Association of ERCC1 polymorphisms and susceptibility to nasopharyngeal carcinoma. Mol Carcinog 2009; 48(3):196-201.
121. Qin HD, Shugart YY, Bei JX et al. Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res 2011; 71(8):3000-3008.
122. Zhuo XL, Cai L, Xiang ZL et al. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis. Arch Med Res 2009; 40(4):299-305.
123. Deng L, Zhao XR, Pan KF et al. Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2002; 34(1):16-20.
124. Catarino RJ, Breda E, Coelho V et al. Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma. Head Neck 2006; 28(7):603-608.
125. Zhou XX, Jia WH, Shen GP et al. Sequence variants in toll-like receptor 10 are associated with nasopharyngeal carcinoma risk. Cancer Epidemiol Biomarkers Prev 2006; 15(5):862-866.
126. He JF, Jia WH, Fan Q et al. Genetic polymorphisms of TLR3 are associated with Nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 2007; 7:194.
127. He Y, Zhou G, Zhai Y et al. Association of PLUNC gene polymorphisms with susceptibility to nasopharyngeal carcinoma in a Chinese population. J Med Genet 2005; 42(2):172-176.
128. Wei YS, Lan Y, Luo B et al. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog 2009; 48(8):751-757.
129. Wei YS, Lan Y, Tang RG et al. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol 2007; 125(3):309-317.
130. Ben Nasr H, Chahed K, Mestiri S et al. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum Immunol 2007; 68(9):761-769.
131. Bel Hadj Jrad B, Mahfouth W, Bouaouina N et al. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction. Cancer Lett 2006; 233(1):21-27.
132. Fan Q, Jia WH, Zhang RH et al. [Correlation of polymeric immunoglobulin receptor gene polymorphisms to susceptibility of nasopharyngeal carcinoma]. Ai Zheng 2005; 24(8):915-918.
133. Chen Y, Chan SH. Polymorphism of T-cell receptor genes in nasopharyngeal carcinoma. Int J Cancer 1994; 56(6):830-833.
134. Ng CC, Yew PY, Puah SM et al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 2009; 54(7):392-397.
135. Tse KP, Su WH, Chang KP et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 2009; 85(2):194-203.
136. Bei JX, Li Y, Jia WH et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 2010; 42(7):599-603.